Commit To Buy Pacific Biosciences of California At $5, Earn 34.4% Annualized Using Options

Investors considering a purchase of Pacific Biosciences of California Inc (PACB) shares, but cautious about paying the going market price of $5.10/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2018 put at the $5 strike, which has a bid at the time of this writing of 90 cents. Collecting that bid as the premium represents a 18% return against the $5 commitment, or a 34.4% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of the S&P 500 »

Selling a put does not give an investor access to PACB's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $5 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Pacific Biosciences of California Inc sees its shares decline 2% and the contract is exercised (resulting in a cost basis of $4.10 per share before broker commissions, subtracting the 90 cents from $5), the only upside to the put seller is from collecting that premium for the 34.4% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Pacific Biosciences of California Inc, and highlighting in green where the $5 strike is located relative to that history:

Loading+chart++2017+TickerTech.com

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the March 2018 put at the $5 strike for the 34.4% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Pacific Biosciences of California Inc (considering the last 252 trading day closing values as well as today's price of $5.10) to be 83%. For other put options contract ideas at the various different available expirations, visit the PACB Stock Options page of StockOptionsChannel.com.

More from Stocks

Stocks Trim Gains At Close After S&P 500 Sets Intraday High

Stocks Trim Gains At Close After S&P 500 Sets Intraday High

Rewind: Jim Cramer on the Bull Market, Kohl's, TJX, Apple and Toll Brothers

Rewind: Jim Cramer on the Bull Market, Kohl's, TJX, Apple and Toll Brothers

Tesla: One Stock Chart That Says It All

Tesla: One Stock Chart That Says It All

Jim Cramer Reacts to Apple's Price Target Raise at Bank of America Merrill Lynch

Jim Cramer Reacts to Apple's Price Target Raise at Bank of America Merrill Lynch

Jim Cramer: Kohl's Is a Buy

Jim Cramer: Kohl's Is a Buy